More than 130 million lab-grown mosquitoes carrying a naturally occurring bacteria called Wolbachia are being released in Vientiane, Laos, to help reduce the spread of deadly viruses such as dengue, Zika, chikungunya, and yellow fever. The initiative comes after global dengue cases surged to a record 14.4 million in 2024, more than double the previous year, with children especially vulnerable to severe illness. The Wolbachia bacteria reduces mosquitoes’ ability to transmit viruses, and once released, these mosquitoes breed with wild populations until they gradually replace them.
The mosquito release is part of a project led by the Ministry of Health in Laos, Save the Children International, the Government of Australia, and the World Mosquito Program. Officials highlighted the importance of this innovative approach in controlling dengue and called on different sectors to support the project for nationwide expansion. Health leaders expressed confidence that cooperation between the government, partners, and local authorities will ensure success.
Supporters of the project emphasized that the method not only addresses current dengue challenges but also provides a long-term solution. Rising temperatures and wetter conditions are increasing the spread of mosquito-borne diseases, making innovative control methods critical. Previous trials in other countries, including Indonesia and Brazil, have shown significant reductions in dengue transmission, offering hope for similar success in Laos.
Australia’s involvement underscores its commitment to strengthening health security in Laos and the broader region. The Wolbachia mosquitoes are bred in Australia, developed into adults in Laos, and then released into communities using reusable cups. By 2028, the program aims to protect more than 1.2 million people across four provinces and the capital.
For residents like Siphat, a village health volunteer who suffered from dengue and spent 12 days in hospital, the project offers hope. He expressed support for the initiative, believing it will help reduce severe cases and improve community health.
Evidence from past projects highlights the effectiveness of Wolbachia mosquitoes. In North Queensland, Australia, dengue transmission dropped significantly, while a large-scale trial in Yogyakarta, Indonesia, recorded a 77% reduction in cases compared with untreated areas. The release in Vientiane will continue over the next five months, with local consent being a key factor for mosquito introduction.
Dengue remains endemic in Laos, with over 20,000 cases and 11 deaths reported in 2024 alone. With climate change, rapid urbanization, and shifting temperatures fueling the spread of mosquito-borne illnesses, the World Health Organization warns that up to 5 billion people could be at risk by 2050. The Wolbachia mosquito program in Laos is seen as a crucial step toward protecting communities from future outbreaks.
